Company insiders that own Atara Biotherapeutics stock include Amar Murugan, Jakob Dupont, Joe Newell, Kristin Yarema, Pascal Touchon, Thomas Peterffy and Utpal Koppikar. View institutional ownership trends for Atara Biotherapeutics. Which major investors are selling Atara Biotherapeutics stock?Who sold Atatra stock in the last quarter?
ATRA stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Credit Suisse AG, Redmile Group LLC, Bridger Management LLC, Healthcare of Ontario Pension Plan Trust Fund, FMR LLC, Alberta Investment Management Corp, and Morgan Stanley.Where can I buy shares of ATRA?
Shares of ATRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.How has Atara Biotherapeutics' stock performed during coronavirus?
Atara Biotherapeutics' stock was trading at $9.96 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ATRA stock has increased by 59.6% and is now trading at $15.90.